Quantifying the impact of norovirus transmission in the community on acute kidney injury hospitalisations in England: a mathematical modelling study

Hikaru Bolt,Pratik R Gupte,Amy Douglas,Frank G Sadmann,Laurie A Tomlinson,Rosalind M Eggo
DOI: https://doi.org/10.1101/2024.10.24.24316053
2024-10-24
Abstract:Norovirus is one of the most common gastrointestinal pathogens and causes substantial morbidity and mortality worldwide. A serious consequence can be acute kidney injury (AKI), characterised by a rapid deterioration of kidney function. A quarter of all inpatients have AKI, which is associated with an increased risk of mortality. This study aimed to quantify the contribution of norovirus community transmission to AKI hospitalisations in England and its attributable cost. We developed an age-structured deterministic compartmental dynamic transmission model for norovirus. We used a Bayesian approach to fit the model to multiple electronic health data sources, including hospitalisations and primary care records for AKI and gastroenteritis, as well as laboratory-confirmed norovirus surveillance data in England, from 2013-2019. We used Markov Chain Monte Carlo to estimate the effect of norovirus incidence on community-acquired AKI hospitalisations. We estimate 25.4% (95% CrI: 17.9-36.3%) of norovirus infections in people aged 65 years and above were linked to community-acquired AKI hospitalisations, amounting to 793,229 (95% CrI: 557,125-1,130,593) hospitalisations between 2013-2019. This represents 16.3% (95% CrI: 11.4-23.2%) of community acquired AKI hospitalisations in people aged 65 years and above over this period. The economic healthcare cost associated with norovirus-linked AKI admissions was estimated to be on average £343 million annually. Gastroenteritis has previously been identified as an important risk factor for AKI in vulnerable patients. Our results suggest norovirus incidence in the community plays an important role in driving AKI hospitalisations in individuals aged 65 years and above. This is the first population-level estimate of the prevalence of norovirus infections linked to hospitalisations for AKI, and the comparable seasonal patterns between the two. This presents a substantial economic burden on the healthcare system and AKI hospitalisation should be an important consideration when evaluating future norovirus vaccines.
What problem does this paper attempt to address?